Evidence-based management of pregnant women with sickle cell disease in high-income countries-Reference-Cited by-同舟云学术

Evidence-based management of pregnant women with sickle cell disease in high-income countries

Published:2022-12-09 Issue:1 Volume:2022 Page:408-413
ISSN:1520-4391
Container-title:Hematology
language:en
Short-container-title:

Author:

Oteng-Ntim Eugene¹²,Shangaris Panicos¹²³

Affiliation:

1. 1 School of Life Course and Population Sciences, King's College London, St Thomas' Hospital, London, UK

2. 2 Department of Women and Children, Guy's and St Thomas' NHS Foundation Trust, London, UK

3. 3 Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK

Abstract

Abstract Globally, patients living with sickle cell disease are now surviving to reproductive age, with life expectancy approaching 50 years in most countries. Thus, reproductive options are now essential for patients living with the condition. However, it can be associated with maternal, delivery, and fetal complications. Outcomes may vary depending on the level of expertise and resources. In this piece we provide an optional guideline for managing sickle cell disease in pregnancy. The therapeutic option of serial exchange prophylactic transfusion has been offered in the context of a clinical trial (TAPS2).

Publisher

American Society of Hematology

Subject

Hematology

Link

https://ashpublications.org/hematology/article-pdf/2022/1/408/2022826/408otengntim.pdf

Reference30 articles.

1. Management of sickle cell disease in pregnancy. A British Society for Haematology Guideline;Oteng-Ntim;Br J Haematol,2021

2. Royal College of Obstetricians and Gynaecologists. Management of sickle cell disease in pregnancy. Accessed 8September2022. https://www.rcog.org.uk/guidance/browse-all-guidance/green-top-guidelines/sickle-cell-disease-in-pregnancy-management-of-green-top-guideline-no-61/.

3. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates;Piel;Lancet,2013

4. Pregnancy outcome in patients with sickle cell disease in the UK—a national cohort study comparing sickle cell anaemia (HbSS) with HbSC disease;Oteng-Ntim;Br J Haematol,2015

5. Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: systematic review and meta-analysis;Oteng-Ntim;Blood,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prophylactic red cell transfusions for sickle cell disease pregnancy: increased use of therapy could transform outcomes;Current Opinion in Hematology;2024-08-15

2. Controversies and Clarifications Regarding the Role of Aspirin in Preeclampsia Prevention: A Focused Review;Journal of Clinical Medicine;2024-07-29

3. Manual Exchange Transfusion Role in the Management of a Pregnancy Compromised by Sickle Cell Disease in a Tertiary Hospital in Burkina Faso: A Case Report;Journal of Gynecology and Obstetrics;2024-05-24

4. Sickle Cell Disease and Pregnancy;Critical Care Obstetrics;2024-04